Page Menu

Mass Spectrometry's Aslebagh presents at the American Society for Mass Spectrometry Conference

Date Posted: Monday, June 17, 2019


June 3, 2019

Roshanak AslebaghRoshanak Aslebagh, a postdoctoral associate in Professor Scott Shaffer’s lab at the Mass Spectrometry Facility, addressed more than 400 attendees in the Qualitative Biomarkers session of the American Society for Mass Spectrometry Conference held in Atlanta, GA (June 2-6, 2019). Dr. Aslebagh described an untargeted metabolomics approach to identify pharmacodynamic biomarkers in urine from children with autism spectrum disorder treated with sulforaphane. Sulforaphane, an isothiocyanate derived from cruciferous vegetables, has been implicated in reducing of behavioral symptoms of autism; however, little is known about its mechanism.

For more about the Mass Spectrometry Facility, please visit www.umassmed.edu/MSF.

Additional Resources
click to open search panel